A Game-Changer for Diabetes: Polymer Delivers Insulin Painlessly Through Skin
November 25, 2025
Brand Name :
EndaCof-DM
(United States) [Available] ,Glenmax PEB DM
(United States) [Available]Synonyms :
Class :
antitussives
Dosage Forms & Strengths Â
oral solution Â
(1mg-5mg-2.5mg)/5ml- brompheniramine-dextromethorphan-phenylephrine Â
 Â
4 teaspoons orally every 4hrs
Do not exceed 120 mL per day
Dosage Forms & Strengths Â
oral solution Â
(1mg-5mg-2.5mg)/5ml- brompheniramine-dextromethorphan-phenylephrine
Age: >12 years
4 teaspoons orally every 4hrs
Do not exceed 120 mL per day
may decrease the therapeutic effects
spironolactone and hydrochlorothiazide
It may enhance the risk of bleeding when combined with Decongestants
It may enhance the risk of bleeding when combined with Decongestants
It may enhance the risk of bleeding when combined with Decongestants
It may enhance the risk of bleeding when combined with Decongestants
It may enhance the risk of bleeding when combined with Decongestants
It may enhance the risk of adverse reactions when combined with Histamine antagonists
It may enhance the risk of adverse reactions when combined with Histamine antagonists
It may enhance the risk of adverse effects when combined with Decongestant
It may enhance the risk of adverse effects when combined with Decongestant
decongestant: they may increase the hypertensive effect of Alpha 2-Agonists
decongestant: they may increase the hypertensive effect of Alpha 2-Agonists
decongestant: they may increase the hypertensive effect of Alpha 2-Agonists
decongestant: they may increase the hypertensive effect of Alpha 2-Agonists
decongestant: they may increase the hypertensive effect of Alpha 2-Agonists
may diminish the serum concentration
spironolactone and hydrochlorothiazide
it may enhance the risk of nephrotoxicity when combined with Diuretics
it may enhance the risk of nephrotoxicity when combined with Diuretics
it may enhance the risk of nephrotoxicity when combined with Diuretics
it may enhance the risk of nephrotoxicity when combined with Diuretics
it may enhance the risk of nephrotoxicity when combined with Diuretics
It may enhance the risk of nephrotoxicity when combined with Dopamine agonists
It may enhance the risk of nephrotoxicity when combined with Dopamine agonists
It may enhance the risk of nephrotoxicity when combined with Dopamine agonists
It may enhance the risk of nephrotoxicity when combined with Dopamine agonists
It may enhance the risk of nephrotoxicity when combined with Dopamine agonists
It may enhance the risk of adverse effects when combined with Fluroquinolones
It may enhance the risk of adverse effects when combined with Fluroquinolones
It may enhance the risk of adverse effects when combined with Fluroquinolones
It may enhance the risk of adverse effects when combined with Fluroquinolones
It may enhance the risk of adverse effects when combined with Fluroquinolones
Adverse drug reactions: Â
Frequency Not Defined Â
Excitability Â
Restlessness Â
Headache Â
Hypertension Â
Dizziness Â
Drowsiness Â
Dry mouth, throat, and nose Â
Thickening of mucus in nose or throat GI disturbances Â
Reflex tachycardia Â
Pregnancy warnings:   Â
Pregnancy Category: CÂ
Breastfeeding warnings:Â
The release of the drug into the human breastmilk is known Â
Pregnancy Categories:     Â
Â
Patient Information Leaflet Â
Generic Name: brompheniramine, dextromethorphan and phenylephrineÂ
Pronounciation: brome-fen-IR-a-meen, dex-troe-meth-OR-fan, fen-il-EFF-rin Â
Why do we use brompheniramine, dextromethorphan and phenylephrine?Â
brompheniramine, dextromethorphan and phenylephrine belong to the class antitussive used to treat the symptoms of allergy and cold